Study highlights a fourfold increase in ME/CFS risk among COVID-19 patients, with 89% of post-COVID ME/CFS cases overlapping with severe long COVID symptom clusters.
A roadmap for making over-the-counter birth control affordable
The Food and Drug Administration recently approved Opill, the first over-the-counter access birth control pill, in a monumental and long overdue win for reproductive and
August 23, 2023